Literature DB >> 24483274

Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.

Michael S Hildebrand1, John A Damiano, Saul A Mullen, Susannah T Bellows, Karen L Oliver, Hans-Henrik M Dahl, Ingrid E Scheffer, Samuel F Berkovic.   

Abstract

The availability of glucose, and its glycolytic product lactate, for cerebral energy metabolism is regulated by specific brain transporters. Inadequate energy delivery leads to neurologic impairment. Haploinsufficiency of the glucose transporter GLUT1 causes a characteristic early onset encephalopathy, and has recently emerged as an important cause of a variety of childhood or later-onset generalized epilepsies and paroxysmal exercise-induced dyskinesia. We explored whether mutations in the genes encoding the other major glucose (GLUT3) or lactate (MCT1/2/3/4) transporters involved in cerebral energy metabolism also cause generalized epilepsies. A cohort of 119 cases with myoclonic astatic epilepsy or early onset absence epilepsy was screened for nucleotide variants in these five candidate genes. No epilepsy-causing mutations were identified, indicating that of the major energetic fuel transporters in the brain, only GLUT1 is clearly associated with generalized epilepsy. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  GLUT1 deficiency; Generalized epilepsy; Glucose metabolism; Glucose transporter; Lactate transporter

Mesh:

Substances:

Year:  2014        PMID: 24483274     DOI: 10.1111/epi.12519

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.

Authors:  Shotaro Sasaki; Yuya Futagi; Masaki Kobayashi; Jiro Ogura; Ken Iseki
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

Review 2.  The Therapeutic Role of Ketogenic Diet in Neurological Disorders.

Authors:  Diana Pietrzak; Kamila Kasperek; Paweł Rękawek; Iwona Piątkowska-Chmiel
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

3.  Clinical Aspects of Glucose Transporter Type 1 Deficiency: Information From a Global Registry.

Authors:  Jian Hao; Dorothy I Kelly; Jianzhong Su; Juan M Pascual
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

Review 4.  Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders.

Authors:  Ajay Uprety; Yeji Kang; Soo Young Kim
Journal:  Arch Pharm Res       Date:  2021-05-24       Impact factor: 4.946

5.  The intolerance to functional genetic variation of protein domains predicts the localization of pathogenic mutations within genes.

Authors:  Ayal B Gussow; Slavé Petrovski; Quanli Wang; Andrew S Allen; David B Goldstein
Journal:  Genome Biol       Date:  2016-01-18       Impact factor: 13.583

6.  Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome.

Authors:  Sachie Nakamura; Hitoshi Osaka; Shin-Ichi Muramatsu; Naomi Takino; Mika Ito; Shiho Aoki; Eriko F Jimbo; Kuniko Shimazaki; Tatsushi Onaka; Sumio Ohtsuki; Tetsuya Terasaki; Takanori Yamagata
Journal:  Mol Genet Metab Rep       Date:  2017-01-15

Review 7.  Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.

Authors:  Armond Daci; Adnan Bozalija; Fisnik Jashari; Shaip Krasniqi
Journal:  Int J Mol Sci       Date:  2018-01-05       Impact factor: 5.923

8.  Continuous monitoring devices and seizure patterns by glucose, time and lateralized seizure onset.

Authors:  Katie M Kinnear; Nicole M Warner; Alan M Haltiner; Michael J Doherty
Journal:  Epilepsy Behav Case Rep       Date:  2018-03-21

Review 9.  Bioenergetic Mechanisms of Seizure Control.

Authors:  Richard Kovács; Zoltan Gerevich; Alon Friedman; Jakub Otáhal; Ofer Prager; Siegrun Gabriel; Nikolaus Berndt
Journal:  Front Cell Neurosci       Date:  2018-10-08       Impact factor: 5.505

Review 10.  Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry.

Authors:  Raffaella Longo; Carolina Peri; Dalma Cricrì; Lara Coppi; Donatella Caruso; Nico Mitro; Emma De Fabiani; Maurizio Crestani
Journal:  Nutrients       Date:  2019-10-17       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.